Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial US$ 25.87 Min. order: 1 piece ★★★★★ 4.5 (186 reviews) Sold : Login>>
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 25.22 Min. order: 1 piece ★★★★★ 5.0 (288 reviews) Sold : Login>>
Updates in Medicine | 🔬 REDEFINE 2: CagriSema in T2D + Obesity Original article link in bio 👥 Phase 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 US$ 24.45 Min. order: 1 piece ★★★★★ 4.8 (47 reviews) Sold : Login>>
Novo Nordisk's CagriSema Falls Short in Head-to-Head Trial vs Zepbound | Bryce Platt, PharmD posted on the topic US$ 25.42 Min. order: 1 piece ★★★★★ 4.6 (115 reviews) Sold : Login>>
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines US$ 20.88 Min. order: 1 piece ★★★★★ 4.5 (233 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 28.08 Min. order: 1 piece ★★★★★ 5.0 (117 reviews) Sold : Login>>